Innovative Therapy Portfolio ONWARD Medical's development of advanced spinal cord stimulation systems such as ARC-EX and ARC-IM positions it as a leader in neurotechnology for movement restoration. This suggests opportunities to collaborate with healthcare providers and clinics seeking cutting-edge therapeutic solutions for spinal cord injuries and related neurological conditions.

Growing Market Presence With recent expansion into the US market and milestones such as CE Mark certification, ONWARD Medical is enhancing its commercial footprint, creating avenues for sales teams to target hospitals, rehab centers, and medical device distributors interested in innovative neurostimulation therapies.

Strategic Funding Momentum The company has secured significant funding rounds totaling over EUR 54 million, indicating strong investor confidence and resources available for product development and market expansion, which can be leveraged to identify new customer segments and strategic partners.

Focus on Neurorehabilitation By targeting mobility challenges in spinal cord injury and Parkinson’s disease patients, ONWARD Medical offers tailored solutions that can appeal to specialists in neurorehabilitation and neurology, opening sales opportunities in specialized clinics and research institutions.

Partnership & Thought Leadership Collaborations with academic institutions like EPFL and participation in major healthcare conferences suggest an opportunity to engage with thought leaders, researchers, and early adopters interested in incorporating the latest neurotechnology into clinical practice and device offerings.